Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Thursday, shares of Coherus BioSciences Inc ( CHRS - Get Report) entered into oversold territory, hitting an RSI reading of 26.9, after changing hands as low as $10.85 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.4. A bullish investor could look at CHRS's 26.9 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CHRS shares: Looking at the chart above, CHRS's low point in its 52 week range is $10.80 per share, with $30.435 as the 52 week high point — that compares with a last trade of $10.85.
More from Stocks
The Fed Cut Rates -- What to Watch Now as FOMC Ponders Second Cut
Here's your interest rate picture, and the key factors that will determine the next Fed rate cut.
Herman Miller Rises After First-Period Earnings, Outlook
The first-quarter profit and second-quarter outlook exceeded estimates. In the first quarter, gross profit margin widened and new orders climbed.
Dow Futures Edge Higher Amid Fed Rate Debate; Fed Runs Third Repo Intervention
Global stocks traded mixed Thursday, with U.S. equity futures indicating modest declines, as investors picked through two major interest rate decisions from major central banks, while preparing for a third later today, while keeping a keen eye on developments in Wall Street's overnight lending markets.